SCHEMBL2800526

SCHEMBL2800526

Cc1ccccc1C1CCN(C(=O)c2cnc3c(Br)cnn3c2NCc2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.43
FLT3 P36888 1/20 0.43
TYRO3 Q06418 1/20 0.43
MERTK Q12866 1/20 0.43
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR2B P41595 1/20 0.40
MAPK14 Q16539 1/20 0.40
MAPT P10636 4/20 0.39
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TACR1 P25103 1/20 0.39
TP53BP1 Q12888 1/20 0.38
L3MBTL3 Q96JM7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4B Q07343 1/20 0.38
GPR119 Q8TDV5 1/20 0.37
TP53 P04637 4/20 0.37
LMNA P02545 2/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800990 0.91 AXL (0.42) AXLFLT3TYRO3MERTKCYP2C9
SCHEMBL2801948 0.90 CHRM4 (0.42) AXLFLT3TYRO3MERTKCYP2C9
SCHEMBL2801439 0.89 ALDH1A1 (0.51) AXLFLT3TYRO3MERTKCYP2C9
SCHEMBL2802845 0.89 STAT6 (0.41) AXLFLT3TYRO3MERTKCYP2C9
SCHEMBL2800587 0.88 STAT6 (0.42) AXLFLT3TYRO3MERTKMAPT
SCHEMBL2801027 0.86 RBP4 (0.40) AXLFLT3TYRO3MERTKCYP2C9
SCHEMBL2801457 0.86 AXL (0.40) AXLFLT3TYRO3MERTKMAPT
SCHEMBL2802395 0.85 KDM4E (0.44) CYP2C9CYP2C19MAPTALDH1A1L3MBTL1
SCHEMBL2801418 0.85 CHRM4 (0.42) MAPTALDH1A1TP53TUBB4ATUBB
SCHEMBL2800878 0.85 TP53BP1 (0.38) AXLFLT3TYRO3MERTKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 AXL 4690/4885FLT3 4427/4885TYRO3 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.